131 related articles for article (PubMed ID: 2545119)
21. Flavobacterium meningosepticum infection, in a 32-day-old child on acute peritoneal dialysis, treated with ciprofloxacin.
Humphreys H; Lovering A; White LO; Williams EW
J Antimicrob Chemother; 1989 Feb; 23(2):292-4. PubMed ID: 2496073
[No Abstract] [Full Text] [Related]
22. Flavobacterium meningosepticum infections in a neonatal intensive care unit.
Abrahamsen TG; Finne PH; Lingaas E
Acta Paediatr Scand; 1989 Jan; 78(1):51-5. PubMed ID: 2919524
[TBL] [Abstract][Full Text] [Related]
23. Emergence of multidrug-resistant isolates of Acinetobacter baumannii.
Okpara AU; Maswoswe JJ
Am J Hosp Pharm; 1994 Nov; 51(21):2671-5. PubMed ID: 7856578
[TBL] [Abstract][Full Text] [Related]
24. Management and epidemiologic analyses of an outbreak due to methicillin-resistant Staphylococcus aureus.
Goetz MB; Mulligan ME; Kwok R; O'Brien H; Caballes C; Garcia JP
Am J Med; 1992 Jun; 92(6):607-14. PubMed ID: 1605142
[TBL] [Abstract][Full Text] [Related]
25. Chryseobacterium meningosepticum infections in a dialysis unit.
Perera S; Palasuntheram C
Ceylon Med J; 2004 Jun; 49(2):57-60. PubMed ID: 15334801
[TBL] [Abstract][Full Text] [Related]
26. Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
Furtado GH; d'Azevedo PA; Santos AF; Gales AC; Pignatari AC; Medeiros EA
Int J Antimicrob Agents; 2007 Oct; 30(4):315-9. PubMed ID: 17631984
[TBL] [Abstract][Full Text] [Related]
27. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review.
Bloch KC; Nadarajah R; Jacobs R
Medicine (Baltimore); 1997 Jan; 76(1):30-41. PubMed ID: 9064486
[TBL] [Abstract][Full Text] [Related]
28. The effect of oropharyngeal decontamination using topical nonabsorbable antibiotics on the incidence of nosocomial respiratory tract infections in multiple trauma patients.
Stoutenbeek CP; van Saene HK; Miranda DR; Zandstra DF; Langrehr D
J Trauma; 1987 Apr; 27(4):357-64. PubMed ID: 3033259
[TBL] [Abstract][Full Text] [Related]
29. [Sensitivity to antibiotics of bacteria from nosocomial infections. Evolution in resuscitation services of military hospitals].
Garrabé E; Cavallo JD; Brisou P; Chapalain JC; Coué JC; Courrier P; Granic G; Hervé V; Koeck JL; Morillon M; Claude JD; Rouby Y; Teyssou R
Presse Med; 2000 Sep; 29(27):1497-503. PubMed ID: 11045115
[TBL] [Abstract][Full Text] [Related]
30. Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis.
Falagas ME; Kasiakou SK
Infection; 2007 Feb; 35(1):3-10. PubMed ID: 17297582
[TBL] [Abstract][Full Text] [Related]
31. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
Nikodemski T
Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
[TBL] [Abstract][Full Text] [Related]
32. Flavobacterium meningosepticum.
Ratner H
Infect Control; 1984 May; 5(5):237-9. PubMed ID: 6563023
[TBL] [Abstract][Full Text] [Related]
33. Outbreak of gentamicin, ciprofloxacin-resistant Pseudomonas aeruginosa in an intensive care unit, traced to contaminated quivers.
Jumaa P; Chattopadhyay B
J Hosp Infect; 1994 Nov; 28(3):209-18. PubMed ID: 7852734
[TBL] [Abstract][Full Text] [Related]
34. Nosocomial infections in an intensive care unit in a private hospital.
Orrett FA
West Indian Med J; 2002 Mar; 51(1):21-4. PubMed ID: 12089869
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and risk factors for nosocomial lower respiratory tract infections in German hospitals.
Kampf G; Wischnewski N; Schulgen G; Schumacher M; Daschner F
J Clin Epidemiol; 1998 Jun; 51(6):495-502. PubMed ID: 9635998
[TBL] [Abstract][Full Text] [Related]
36. Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital's intensive care and intermediate care units.
Lewis GJ; Fang X; Gooch M; Cook PP
Infect Control Hosp Epidemiol; 2012 Apr; 33(4):368-73. PubMed ID: 22418632
[TBL] [Abstract][Full Text] [Related]
37. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
[TBL] [Abstract][Full Text] [Related]
38. [Outbreak of a nosocomial infection of SHV2-beta-lactamase-containing Klebsiella pneumonia strains in an operative intensive care unit].
Ritter E; Bauernfeind A; Becker-Boost E; Fiehn A; Stöcker H; Wirsing von König CH; Finger H
Immun Infekt; 1992 Feb; 20(1):3-6. PubMed ID: 1563756
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.
Jones RN; Kehrberg EN; Erwin ME; Anderson SC
Diagn Microbiol Infect Dis; 1994 Aug; 19(4):203-15. PubMed ID: 7851083
[TBL] [Abstract][Full Text] [Related]
40. A nosocomial common source outbreak caused by Pseudomonas pickettii.
Gardner S; Shulman ST
Pediatr Infect Dis; 1984; 3(5):420-2. PubMed ID: 6494013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
